Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02273206 · ClinicalTrials.gov registry record · NA

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

A NA study of Depression and Colorectal Cancer Screening, sponsored by Clinical Directors Network.

Completed
Registry status
NA
Development phase
802
Enrollment target
8
Study locations

NCT02273206: Completed NA study of Depression and Colorectal Cancer Screening, sponsored by Clinical Directors Network.

NCT02273206 is a NA study of Depression and Colorectal Cancer Screening that has completed, run by Clinical Directors Network. The registered enrollment target is 802 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02273206, a NA study of Depression and Colorectal Cancer Screening, has completed, sponsored by Clinical Directors Network.

COMPLETED
Registry status
NA
Development phase
802 participants
Enrollment target
8
Study locations

Study Summary

Bronx County, New York is the poorest urban county in the U.S.A., and residents are almost entirely Latino or African American. Cancer is the leading cause of premature death in the Bronx, with morality rates significantly higher than for New York City as a whole. Low-income/minority populations are more likely to be diagnosed with preventable and late-stage cancers than the general population, in part, due to lower screening rates. While research has addressed screening barriers in low-income/minority groups, depression, a common,potentially critical barrier, has received scant attention. Research suggests that depressed women are less likely to engage in cancer screening, especially mammography and Pap testing. The link between mental health and cancer screening is particularly important to address in the Bronx, which has the highest rates of self-reported serious psychological distress (a measure closely related to depression) in New York City. Depression affects almost 1 in 4 minority women, and while minorities often seek help for depression in primary care, primary care depression management often does not meet evidence-based standards. Drawing on the expertise and close collaboration of Bronx medical and social service providers and patient stakeholders, this study will determine whether a collaborative care intervention that addresses both depression and cancer screening needs simultaneously among women ages 50-64 is more effective at improving cancer screening and patient-reported outcomes for women with depression than an existing evidence-based cancer screening intervention alone. To achieve this, the investigators will compare the effectiveness of these two interventions using a randomized controlled trial (RCT). In partnership with six Bronx Federally Qualified Health Centers (FQHCs), the investigators will recruit approximately 800 women ages 50-64 who screen positive for depression and are non-adherent with recommended cervical, breast, and/or colore

Primary Outcome

Comparison of the proportion of patients who were up to date for colorectal cancer, breast cancer and cervical cancer screenings before and after the intervention. (Chart Review)

Interventions

  • BEHAVIORAL Prevention Care Management for Depression and Cancer Screening
  • BEHAVIORAL Prevention Care Management for Cancer Screening

Study Locations (8)

New York

  • Lincoln Ambulatory Care Practice - The Bronx
  • Morrissania Diagnostic and Treatment Center - The Bronx
  • Morris Heights Health Center - The Bronx
  • Segundo Ruiz Belvis Diagnostic and Treatment Center - The Bronx
  • BronwWorks - The Bronx
  • Urban Health Plan - The Bronx
  • Montefiore Family Care Center - The Bronx
  • Good Shepherd Service - The Bronx

Trial Details

FieldValue
Enrollment Target 802 participants
Start Date 2014-01
Est. Completion 2017-12-31
Phase NA
Clinical Directors Network

1 total trials

What the finished NCT02273206 record still lists

NCT02273206 is an interventional study that assigns participants to a tested intervention. The registered 802 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Prevention Care Management for Depression and Cancer Screening is the first listed.

NCT02273206 lists 8 locations in 1 state (New York).

Frequently Asked Questions

What is clinical trial NCT02273206 about?

NCT02273206 is a clinical study titled "Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women". Bronx County, New York is the poorest urban county in the U.S.A., and residents are almost entirely Latino or African American. Cancer is the leading cause of premature death in the Bronx, with morality rates significantly higher than for New York City as a whole. Low-income/minority populations are...

What is the current status of trial NCT02273206?

This trial is currently completed. It is a NA study. The enrollment target is 802 participants. The study started on 2014-01. Estimated completion is 2017-12-31.

What conditions does trial NCT02273206 study?

This clinical trial studies the following conditions: Depression, Colorectal Cancer Screening, Breast Cancer Screening, Cervical Cancer Screening.

What interventions are being tested in trial NCT02273206?

The interventions under investigation include: Prevention Care Management for Depression and Cancer Screening (BEHAVIORAL), Prevention Care Management for Cancer Screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT02273206?

This trial is sponsored by Clinical Directors Network, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02273206 being conducted?

This trial has 8 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02273206's enrollment target sits among peer trials

802 53rd of 679 higher than 627 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03524430 · 801 participants · NA

    RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

  • NCT04423211 · 804 participants · Phase 3

    Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • NCT06522022 · 804 participants · NA

    PTSD Screening in Pregnant Black Women

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02273206, the US trial registry maintained by the National Library of Medicine. NCT02273206 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.